Building the global evidence platform to protect long-term BoNT-A outcomes.
Phase 1 of 3 · Design & de-risk
Cognitive interviews are under way to pressure-test the questionnaire · market materials and translations prepared for all eight countries · protocol in final review ahead of ethics submission.
1 · Design & de-risk
2 · Generate & interpret evidence
3 · Translate evidence
CompleteIn progressNextFuture
Study phases
1
Design & de-riskIn progress
Kick-off
Literature review
KOL contracting
Hypothesis validation
Datamap & questionnaire
Questionnaire sign-off
Questionnaire translation
Cognitive interviews
Finalize questionnaire
Protocol
IRB exemption determination
2
Generate & interpret evidenceFuture
Survey programming
Fieldwork
Data processing & analysis
Reporting & presentation
Narrative & strategy alignment
3
Translate evidenceFuture
Manuscript development
Journal submission
Execution workshopOptional
Next steps for KOLs: The final study protocol reaches you in the week of 1 September. Please return your comments by 8 September so the ethics submission stays on schedule.
Key dates
Now · Aug 2026
Sep 2026
Questionnaire finalized
Oct–Nov 2026
Fieldwork
Nov 2026
MAX Summit
Jan 2027
Insight readout
Jan 2027
IMCAS
Jun 2027
Journal submission
Now · Aug 2026
Sep 2026
Questionnaire finalized
Oct–Nov 2026
Fieldwork
Nov 2026
MAX Summit
Jan 2027
Insight readout
Jan 2027
IMCAS
Jun 2027
Journal submission
Project management by Advocates for Advancing Health & Tech ObserverStudy sponsor: Merz AestheticsConfidential